瑞聯新材(688550.SH):第一大股東、實控人、董事及高管所持股份延長鎖定期
格隆匯 10 月 12日丨瑞聯新材(688550.SH)公佈,公司第一大股東北京卓世恆立投資基金管理中心(有限合夥)(“卓世合夥”)持有公司股份鎖定期延長6個月至2024年3月1日。
公司實際控制人劉曉春、呂浩平、李佳凝直接/間接的公司股份鎖定期延長6個月至2024年3月1日。
公司董事劉騫峯、王子中和高仁孝持有的公司股份鎖定期延長6個月至2022年3月1日。
公司高級管理人員劉騫峯、王小偉、陳謙、王銀彬、袁江波、張波、錢曉波持有的公司股份鎖定期延長6個月至2022年3月1日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.